Randomized Trialhigh evidence
Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.
Nature medicine·July 2, 2026·PMID 42393373
Why it mattersDespite strong evidence for GDMT in HFrEF, real-world adherence and uptitration remain poor, especially in underserved populations. This trial shows that a simplified polypill strategy can improve both cardiac function and clinical outcomes, offering a practical solution to a persistent implementation gap.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled